Wikipedia -WSS

Wikipedia

author：focus 2025-09-29 12:30:02 - browse：88

Sarepta - Cambridge -AP — A logo sign outside of the headquarters of Sarepta Therapeutics in Cambridge, Mass. Kristoffer Tripplaar/Sipa via AP

Reviewers at the Food and Drug Administration were leaning toward rejecting a closely watched gene therapy for Duchenne muscular dystrophy made by Sarepta Therapeutics, prompting a top official to intervene earlier this year, according to three people with direct knowledge of the agency deliberations.

Inside the FDA office that oversees gene therapies, some staff had reached a non-binding conclusion that Sarepta’s gene therapy should be rejected, the individuals said, speaking on condition of anonymity. Peter Marks, a top FDA official and vocal advocate for faster gene therapy approvals, stepped in and directed staff to schedule a public hearing on the therapy on May 12.

Sarepta announced the scheduling of the public hearing last month, but the internal deliberations that led to it have not been previously reported.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Why Novartis is changing the name of its research labs

WSS

Illumina names Agilent executive as new CEO

'Make People Better': The CRISPR babies story you probably don't know

Living organ donors deserve priority status for transplants

Senate panel passes drug pricing bills, but drops one PBM reform

Can medical device makers keep up in the race to treat obesity?

Listen: Biogen's potential pivot, & Illumina's next chapter

hotspot

Wikipedia

explore

Hollywood unions extend contract negotiations for actors

Novo pauses ads for weight loss drug Wegovy amid demand

In Memoriam: Notable people who died in 2023

NIH nominee Bertagnolli will get October confirmation hearing

New air purifier tech could be key to improving indoor air quality

How to fix cancer clinical trials' diversity problem

DIEP, the 'gold standard' of breast reconstruction, is under threat

ALS advocates say criticism of new drugs misses bigger picture

Cancer drug shortages should be causing more outrage

Medicaid rebukes states for mistakenly disenrolling children

entertainment

Weighted lottery helped low

Novo pauses ads for weight loss drug Wegovy amid demand

Biotech execs pursue obesity drug boom: ‘It’s the early innings’

Novo: Oral version of Ozempic leads to 15% weight loss

Inside the rise of 'mukbang' eating videos

Patients, doctors are clashing about side effects of hormonal birth control

knowledge

focus

hotspot

Wikipedia